Validation of an albumin-indocyanine green-based China liver cancer staging system to evaluating resectable hepatocellular carcinoma patients and comparison with the Child-Pugh-based China liver cancer staging system
The ALICE-CNLC and CNLC staging systems did not show significant differences in predicting the prognosis of patients with HCC who have undergone hepatectomy.
Authors
- M S Chen (ORCID: https://orcid.org/0009-0002-8101-2603)
- Jie Jin (ORCID: https://orcid.org/0009-0005-1334-4683)
- B.A. Zhuang (ORCID: https://orcid.org/0000-0002-2052-793X)
- Yu Min (ORCID: https://orcid.org/0000-0002-1266-3325)
- Yaoqi Zhang (ORCID: https://orcid.org/0009-0003-3853-2256)
- MengXia Wang
- Bo Wu (ORCID: https://orcid.org/0000-0003-4215-2101)
- Chao Ren (ORCID: https://orcid.org/0000-0003-1872-2063)
- Shi‐Cang Yu (ORCID: https://orcid.org/0000-0001-6151-1224)
Institutions
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.3389/fonc.2025.1450333
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32